Scientists create smart cells that administer automatic treatments from inside the human body, reacting within seconds to ...

In July 2025, Inovio Pharmaceuticals conducted a Phase 1/2 trial to evaluate safety, immunogenicity and preliminary efficacy ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

Rather than functioning in isolation, the activities of nuclear factor (NF)-κB and inhibitor of NF-κB kinase (IKK) proteins are integrated with diverse cell-signalling pathways, including the ...